Related Experiment Video
Updated: Jul 26, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
Published on: October 20, 2020
Red Light-Triggered Polyethylene Glycol Deshielding from Photolabile Cyanine-Modified Mesoporous Silica Nanoparticles
Xiaojing Li1, Wen Sun1,2, Zhen Zhang1
1State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China.
Abstract:
PEGylation of drug delivery systems (DDSs) provides a promising approach to overcome the side effect of traditional chemotherapy via the enhanced permeability and retention (EPR) effect, although it further inhibits the internalization behavior of nanocarriers. PEGylation/dePEGylation of the nanocarriers at the desired site exhibits great advantages for nanocarrier-based on-demand drug release. Here, we reported a photoinduced polyethylene glycol (PEG) deshielding nanocarrier, SiO2@DOX-Cy-PEG, for on-demand drug release in an acidic tumor microenvironment. SiO2@DOX nanoparticles were functionalized with PEG-alkyne chains by click reaction with the photolabile cyanine-azide linkers. Under red light irradiation (650 nm), doxorubicin (DOX) can be effectively released from mesoporous silica nanoparticles (MSNs) due to the photolysis of Cy, resulting in the cleavage of the linkers and PEG deshielding in cancer cells. Therefore, SiO2@DOX-Cy-PEG nanoparticles with irradiation arouse a higher cell apoptosis and death ratio, further proving that dePEGylation of MSNs accelerates the release of DOX. In addition, the experiment of the antitumor effect in vivo demonstrated that dePEGylation of the SiO2@DOX-Cy-PEG could effectively promote the therapeutic effect on xenografted 4T1 tumor-bearing BALB/c mice. The results suggested that SiO2@DOX-Cy-PEG was a precisely and remotely on-demand drug delivery system controlled by red light.
Related Concept Videos
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Delayed-Release Systems

